[HTML][HTML] Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic …
M Jones, A Boisvert, J Landry, PF Petrasek - CMAJ, 2021 - Can Med Assoc
• The clinical presentation and pathobiology of VITT are similar to those of heparin-induced
thrombocytopenia (HIT), but in VITT, an immunoglobulin G (IgG) antibody against platelet …
thrombocytopenia (HIT), but in VITT, an immunoglobulin G (IgG) antibody against platelet …
[HTML][HTML] A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis
MC Turi, F Spitaleri, AM Gori, G Parruti… - Blood …, 2021 - ncbi.nlm.nih.gov
DISCUSSION VITT is a rare adverse event recently reported after administration of the
ChAdOx1 nCoV-19 Astra Zeneca vaccine 3, 4. Recognition of early signs of the pathogenic …
ChAdOx1 nCoV-19 Astra Zeneca vaccine 3, 4. Recognition of early signs of the pathogenic …
[HTML][HTML] Vaccine‐induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine–A case report
B Al Rawahi, H BaTaher, Z Jaffer, A Al‐Balushi… - Research and Practice …, 2021 - Elsevier
Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic
thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia …
thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia …
[HTML][HTML] Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination
N Gabarin, S Patterson, M Pai, T Afzaal… - Thrombosis and …, 2021 - thieme-connect.com
Thrombocytopenia and thrombosis have been reported following vaccination with the
ChAdOx1 nCoV-19 (AstraZeneca) vaccine, an adenoviral vector COVID-19 (coronavirus …
ChAdOx1 nCoV-19 (AstraZeneca) vaccine, an adenoviral vector COVID-19 (coronavirus …
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: less severe but remains a problem
L Clarke, T Brighton, SD Chunilal, CSM Lee, F Passam… - Vaccine, 2023 - Elsevier
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but
established complication of 1st dose ChAdOx1 nCoV19 vaccination (AZD1222), however …
established complication of 1st dose ChAdOx1 nCoV19 vaccination (AZD1222), however …
Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination
S Platton, A Bartlett, P MacCallum… - … of Thrombosis and …, 2021 - Wiley Online Library
Introduction Vaccine‐induced immune thrombocytopenia and thrombosis (VITT) following
ChAdOx1 nCOV‐19 vaccine has been described, associated with unusual site thrombosis …
ChAdOx1 nCOV‐19 vaccine has been described, associated with unusual site thrombosis …
[HTML][HTML] Heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination and safety of second vaccination with …
E Lindhoff-Last, L Schoenborn… - Thrombosis and …, 2022 - thieme-connect.com
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare side effect of two
adenoviral vector vaccines, ChAdOx1 nCoV-19 (AstraZeneca) and Ad26. COV2. S (Johnson …
adenoviral vector vaccines, ChAdOx1 nCoV-19 (AstraZeneca) and Ad26. COV2. S (Johnson …
A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital
I Watts, D Smith, S Mounter, EH Baker… - British Journal of …, 2022 - Wiley Online Library
The ChAdOx1 nCoV‐19 vaccine has been associated with increased risk of thrombosis.
Understanding of the management of these rare events is evolving, and currently …
Understanding of the management of these rare events is evolving, and currently …
[HTML][HTML] Elevated NETs and calprotectin levels after ChAdOx1 nCoV-19 vaccination correlate with the severity of side effects
G Hetland, MK Fagerhol, MKH Wiedmann, AVL Søraas… - Vaccines, 2022 - mdpi.com
ChAdOx1 nCoV-19 vaccination has been associated with the rare side effect; vaccine-
induced immune thrombotic thrombocytopenia (VITT). The mechanism of thrombosis in VITT …
induced immune thrombotic thrombocytopenia (VITT). The mechanism of thrombosis in VITT …
PF4-dependent immunoassays in patients with vaccine-induced immune thrombotic thrombocytopenia: results of an interlaboratory comparison
UJ Sachs, N Cooper, A Czwalinna… - Thrombosis and …, 2021 - thieme-connect.com
Background Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to
vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 …
vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 …